Solventum Corporation
SOLVNYSEHealthcare● Active
$79.71
$-1.30(-1.60%)
Market Cap$13.8B
P/E Ratio—
52W High$88.2
52W Low$62.38
Solventum Corporation (SOLV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SOLV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B | $8.17B |
| Cost of Revenue | $3.87B | $3.66B | $3.50B | $3.44B | $3.25B |
| Gross Profit | $4.45B | $4.59B | $4.69B | $4.70B | $4.92B |
| Gross Margin %(computed) | 53.47% | 55.65% | 57.25% | 57.75% | 60.25% |
| Operating Expenses | |||||
| R&D Expenses | $0.74B | $0.78B | $0.76B | $0.77B | $0.77B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $2.27B | $3.56B | $3.00B | $3.00B | $3.04B |
| Operating Income | $2.18B | $1.04B | $1.69B | $1.69B | $1.88B |
| Operating Margin %(computed) | 26.20% | 12.55% | 20.64% | 20.82% | 23.00% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.35B | $0.37B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $1.71B | $0.60B | $1.67B | $1.69B | $1.88B |
| Income Tax Expense | $0.16B | $0.13B | $0.32B | $0.35B | $0.42B |
| Net Income | $1.56B | $0.48B | $1.35B | $1.34B | $1.46B |
| Net Margin %(computed) | 18.69% | 5.80% | 16.42% | 16.52% | 17.87% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $8.94 | $2.77 | $7.79 | $7.79 | $8.47 |
| Wtd Avg Shares | 0.17B | 0.17B | 0.17B | 0.17B | 0.17B |
| EBITDA | $2.55B | $1.53B | $2.23B | $2.27B | $2.48B |
| EBITDA Margin %(computed) | 30.62% | 18.50% | 27.18% | 27.92% | 30.30% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Solventum Corporation data
About Solventum Corporation (SOLV) Income Statement
Solventum Corporation (SOLV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SOLV reported revenue of $8.32B, gross profit of $4.45B (gross margin 53.47%), and net income of $1.56B — a net profit margin of 18.69%.
Frequently asked questions
SOLV · 4 questionsSolventum Corporation (SOLV) reported revenue of $8.32B for 2025, up 0.9% year-over-year.
SOLV revenueSOLV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08